Fractyl Health to Participate in the 8th Annual Evercore Healthcare Conference
Fractyl Health (Nasdaq: GUTS) announced that Harith Rajagopalan, M.D., Ph.D., Co-Founder and Chief Executive Officer, will participate in a fireside chat at the 8th Annual Evercore Healthcare Conference in Coral Gables, FL.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Fractyl Health (Nasdaq: GUTS) announced that Harith Rajagopalan, M.D., Ph.D., Co-Founder and Chief Executive Officer, will participate in a fireside chat at the 8th Annual Evercore Healthcare Conference in Coral Gables, FL.
Event format: fireside chat and one-on-one meetings. Date and time: December 3, 2025 at 1:45 PM ET. A webcast replay will be available on the company’s investor events page at https://ir.fractyl.com/.
Details
News Market Reaction – GUTS
On Dec 1, the day this news came out, GUTS closed 0.64% below the previous close.
Data tracked by StockTitan Argus for the Dec 1 session.
Key Figures
- Conference dates
- December 2–4, 2025
- 8th Annual Evercore Healthcare Conference
- Fireside chat date
- 12/03/2025
- Scheduled investor session at Evercore conference
- Fireside chat time
- 1:45 PM ET
- Timing of Fractyl Health’s conference appearance
- Share price
- $2.30
- Pre‑news price versus 52‑week range
- 52‑week high
- $3.03
- Upper end of 52‑week trading range
- 52‑week low
- $0.825
- Lower end of 52‑week trading range
Historical Context
-
Positive 6‑month REVEAL‑1 results with sustained weight maintenance data.
-
Announcement of participation in Evercore healthcare investor conference.
-
Q3 2025 results with Revita/Rejuva progress and cash runway into 2027.
-
Scheduling of Q3 2025 results call and webcast details.
-
Potent RJVA‑002 preclinical obesity data in a mouse model.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Key Terms
type 2 diabetes medical
webcast technical
AI-generated analysis. How Rhea-AI works. Not financial advice.
BURLINGTON, Mass., Dec. 01, 2025 (GLOBE NEWSWIRE) -- Fractyl Health, Inc. (Nasdaq: GUTS) (the Company or Fractyl), a metabolic therapeutics company focused on pattern-breaking approaches that treat root causes of obesity and type 2 diabetes (T2D), today announced that Harith Rajagopalan, M.D., Ph.D., Co-Founder and Chief Executive Officer of the Company, will be participating in a fireside chat at the 8th Annual Evercore Healthcare Conference, being held December 2-4, 2025, in Coral Gables, FL.
8th Annual Evercore Conference
Format: Fireside chat and one-on-one meetings
Date: 12/03/2025
Time: 1:45 PM ET
A webcast replay will be accessible following the live session on the Events page of the Investors section on the Company’s website at https://ir.fractyl.com/
About Fractyl Health
Fractyl Health is a metabolic therapeutics company focused on pioneering new approaches to the treatment of metabolic diseases, including obesity and T2D. Despite advances in treatment over the last 50 years, obesity and T2D continue to be rapidly growing drivers of morbidity and mortality in the 21st century. Fractyl’s goal is to transform metabolic disease treatment from chronic symptomatic management to durable disease-modifying therapies that target the organ-level root causes of disease. The Company has a robust and growing IP portfolio, with 33 granted U.S. patents and approximately 45 pending U.S. applications, along with numerous foreign issued patents and pending applications. Fractyl is based in Burlington, MA. For more information, visit www.fractyl.com.
Contact
Brian Luque, Head of Investor Relations and Corporate Development
IR@fractyl.com, 951.206.1200
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.